세계의 입자선 치료 시장 : 제품 및 서비스, 용도, 암 유형, 유형, 시스템, 16개 이상 국가의 데이터에 대한 초점 - 분석과 예측(2024-2033년)

“Global Particle Therapy Market Surges Ahead with Unprecedented Growth.”

Particle therapy, a specialized form of external beam radiotherapy utilizing energetic protons, neutrons, or heavy positive ions, is gaining traction in cancer treatment. Market expansion is primarily propelled by factors such as the increasing incidence of cancer, heightened adoption of particle therapy in clinical research, continual technological advancements, and the proliferation of particle therapy centres worldwide.

The study evaluates the competitive landscape, profiling leading players, and assessing their strategies to gain a competitive edge. Additionally, the report discusses the factors driving market growth, challenges and potential risks are addressed, aiding stakeholders in making informed decisions.

With a blend of quantitative and qualitative analysis, this report serves as a valuable resource for industry participants, investors, and decision-makers seeking to understand the dynamics of the global particle therapy market.

Market Segmentation:

Segmentation 1: by Application

• Treatment
• Research

Segmentation 2: by Cancer Type

• Paediatric Cancer
• Lung Cancer
• Breast Cancer
• Head and Neck Cancer
• Other Cancers

Segmentation 3: by Type

• Proton Therapy
• Heavy-Ion Therapy

Segmentation 4: by System

• Multi-room Systems
• Single-room Systems

Segmentation 6: by Region

• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

Key Questions Answered in this Report:

• 1. What is the present size of the global market for particle therapy?

• 2. Who are the major contributors in the global particle therapy Market?

• 3. Which region is experiencing the most rapid growth in the global particle therapy Market?

• 4. Which geographical area holds the largest portion of the global particle therapy Market?

• 5. What is the projected Compound Annual Growth Rate (CAGR) for the particle therapy market?

• 6. What are the primary factors propelling growth in the particle therapy market?

• 7. Which sector is predicted to spearhead the particle therapy market by 2033?

Table of Contents

Executive Summary

Scope and Definition

1. Markets

• 1.1. Trends: Current and Future Impact Assessment
  • 1.1.1. Sample Text
  • 1.1.2. Trend 1- Technological Advancements
  • 1.1.3. Trend 2
  • 1.1.4. Trend 3
• 1.2. Supply Chain Overview
  • 1.2.1. Value Chain Analysis
  • 1.2.2. Market Map
• 1.3. Research and Development Review
  • 1.3.1. Patent Filing Trend (by Country, Company)
• 1.4. Regulatory Landscape
• 1.5. Impact Analysis for Key Global Events- Covid19
• 1.6. Market Dynamics Overview
  • 1.6.1. Market Drivers
  • 1.6.2. Market Restraints
  • 1.6.3. Market Opportunities

2. Application

• 2.1. Application Segmentation
• 2.2. Application Summary
• 2.3. Global Particle Therapy Market (by Application)
  • 2.3.1. Treatment
  • 2.3.2. Research
• 2.4. Global Particle Therapy Market (by Cancer Type)
  • 2.4.1. Paediatric Cancer
  • 2.4.2. Lung Cancer
  • 2.4.3. Breast Cancer
  • 2.4.4. Head and Neck Cancer
  • 2.4.5. Other Cancers

3. Products

• 3.1. Product Segmentation
• 3.2. Product Summary
• 3.3. Global Particle Therapy Market (by Products and Services)
  • 3.3.1. Products
  • 3.3.2. Services
• 3.4. Global Particle Therapy Market (by Type)
  • 3.4.1. Proton Therapy
  • 3.4.2. Heavy-Ion Therapy
• 3.5. Global Particle Therapy Market (By System)
  • 3.5.1. Multi-room Systems
  • 3.5.2. Single-room Systems

4. Regions

• 4.1. Regional Summary
• 4.2. Drivers and Restraints as you go alone……
• 4.3. North America
  • 4.3.1. Regional Overview
  • 4.3.2. Driving Factors for Market Growth
  • 4.3.3. Factors Challenging the Market
  • 4.3.4. Application
  • 4.3.5. Product
  • 4.3.6. U.S.
  • 4.3.7. U.S. Particle Therapy Market by Application
  • 4.3.8. Canada
  • 4.3.9. Canada Particle Therapy Market by Application
• 4.4. Europe
  • 4.4.1. Regional Overview
  • 4.4.2. Driving Factors for Market Growth
  • 4.4.3. Factors Challenging the Market
  • 4.4.4. Application
  • 4.4.5. Product
  • 4.4.6. France
  • 4.4.7. France Particle Therapy Market by Application
  • 4.4.8. Germany
  • 4.4.9. Germany Particle Therapy Market by Application
  • 4.4.10. U.K.
  • 4.4.11. U.K. Particle Therapy Market by Application
  • 4.4.12. Rest of Europe
  • 4.4.13. Rest of Europe Particle Therapy Market by Application
• 4.5. Asia Pacific
  • 4.5.1. Regional Overview
  • 4.5.2. Driving Factors for Market Growth
  • 4.5.3. Factors Challenging the Market
  • 4.5.4. Application
  • 4.5.5. Product
  • 4.5.6. China
  • 4.5.7. China Particle Therapy Market by Application
  • 4.5.8. India
  • 4.5.9. India Particle Therapy Market by Application
  • 4.5.10. Japan
  • 4.5.11. Japan Particle Therapy Market by Application
  • 4.5.12. Rest-of-Asia-Pacific
  • 4.5.13. Rest-of-Asia-Pacific Particle Therapy Market by Application
• 4.6. Rest-of-the-World
  • 4.6.1. Regional Overview
  • 4.6.2. Driving Factors for Market Growth
  • 4.6.3. Factors Challenging the Market
  • 4.6.4. Application
  • 4.6.5. Product
  • 4.6.6. The Middle East and Africa
  • 4.6.7. The Middle East and Africa Particle Therapy Market by Application
  • 4.6.8. Latin America
  • 4.6.9. Latin America Particle Therapy Market by Application

5. Markets - Competitive Benchmarking & Company Profiles

• 5.1. Next Frontiers
• 5.2. Geographic Assessment
  • 5.2.1. Advanced Oncotherapy Plc.
    • 5.2.1.1. Overview
    • 5.2.1.2. Top Products / Product Portfolio
    • 5.2.1.3. Top Competitors
    • 5.2.1.4. Target Customers
    • 5.2.1.5. Key Personnel
    • 5.2.1.6. Analyst View
    • 5.2.1.7. Market Share
  • 5.2.2. Biosig Technologies, Inc.
    • 5.2.2.1. Overview
    • 5.2.2.2. Top Products / Product Portfolio
    • 5.2.2.3. Top Competitors
    • 5.2.2.4. Target Customers
    • 5.2.2.5. Key Personnel
    • 5.2.2.6. Analyst View
    • 5.2.2.7. Market Share
  • 5.2.3. Danfysik A/S
    • 5.2.3.1. Overview
    • 5.2.3.2. Top Products / Product Portfolio
    • 5.2.3.3. Top Competitors
    • 5.2.3.4. Target Customers
    • 5.2.3.5. Key Personnel
    • 5.2.3.6. Analyst View
    • 5.2.3.7. Market Share
  • 5.2.4. Elekta
    • 5.2.4.1. Overview
    • 5.2.4.2. Top Products / Product Portfolio
    • 5.2.4.3. Top Competitors
    • 5.2.4.4. Target Customers
    • 5.2.4.5. Key Personnel
    • 5.2.4.6. Analyst View
    • 5.2.4.7. Market Share
  • 5.2.5. Hitachi Ltd.
    • 5.2.5.1. Overview
    • 5.2.5.2. Top Products / Product Portfolio
    • 5.2.5.3. Top Competitors
    • 5.2.5.4. Target Customers
    • 5.2.5.5. Key Personnel
    • 5.2.5.6. Analyst View
    • 5.2.5.7. Market Share
  • 5.2.6. IBA
    • 5.2.6.1. Overview
    • 5.2.6.2. Top Products / Product Portfolio
    • 5.2.6.3. Top Competitors
    • 5.2.6.4. Target Customers
    • 5.2.6.5. Key Personnel
    • 5.2.6.6. Analyst View
    • 5.2.6.7. Market Share
  • 5.2.7. Mevion Medical Systems
    • 5.2.7.1. Overview
    • 5.2.7.2. Top Products / Product Portfolio
    • 5.2.7.3. Top Competitors
    • 5.2.7.4. Target Customers
    • 5.2.7.5. Key Personnel
    • 5.2.7.6. Analyst View
    • 5.2.7.7. Market Share
  • 5.2.8. Panacea Medical Technologies
    • 5.2.8.1. Overview
    • 5.2.8.2. Top Products / Product Portfolio
    • 5.2.8.3. Top Competitors
    • 5.2.8.4. Target Customers
    • 5.2.8.5. Key Personnel
    • 5.2.8.6. Analyst View
    • 5.2.8.7. Market Share
  • 5.2.9. Optivus Proton Therapy, Inc.
    • 5.2.9.1. Overview
    • 5.2.9.2. Top Products / Product Portfolio
    • 5.2.9.3. Top Competitors
    • 5.2.9.4. Target Customers
    • 5.2.9.5. Key Personnel
    • 5.2.9.6. Analyst View
    • 5.2.9.7. Market Share
  • 5.2.10. P-Cure
    • 5.2.10.1. Overview
    • 5.2.10.2. Top Products / Product Portfolio
    • 5.2.10.3. Top Competitors
    • 5.2.10.4. Target Customers
    • 5.2.10.5. Key Personnel
    • 5.2.10.6. Analyst View
    • 5.2.10.7. Market Share
  • 5.2.11. ProTom International
    • 5.2.11.1. Overview
    • 5.2.11.2. Top Products / Product Portfolio
    • 5.2.11.3. Top Competitors
    • 5.2.11.4. Target Customers
    • 5.2.11.5. Key Personnel
    • 5.2.11.6. Analyst View
    • 5.2.11.7. Market Share
  • 5.2.12. Provision Healthcare
    • 5.2.12.1. Overview
    • 5.2.12.2. Top Products / Product Portfolio
    • 5.2.12.3. Top Competitors
    • 5.2.12.4. Target Customers
    • 5.2.12.5. Key Personnel
    • 5.2.12.6. Analyst View
    • 5.2.12.7. Market Share
  • 5.2.13. Siemens Healthcare GmbH (Variant Medical Systems, Inc.)
    • 5.2.13.1. Overview
    • 5.2.13.2. Top Products / Product Portfolio
    • 5.2.13.3. Top Competitors
    • 5.2.13.4. Target Customers
    • 5.2.13.5. Key Personnel
    • 5.2.13.6. Analyst View
    • 5.2.13.7. Market Share
  • 5.2.14. Sumitomo Heavy Industries, Ltd.
    • 5.2.14.1. Overview
    • 5.2.14.2. Top Products / Product Portfolio
    • 5.2.14.3. Top Competitors
    • 5.2.14.4. Target Customers
    • 5.2.14.5. Key Personnel
    • 5.2.14.6. Analyst View
    • 5.2.14.7. Market Share
  • 5.2.15. Toshiba Medical Systems Corp.
    • 5.2.15.1. Overview
    • 5.2.15.2. Top Products / Product Portfolio
    • 5.2.15.3. Top Competitors
    • 5.2.15.4. Target Customers
    • 5.2.15.5. Key Personnel
    • 5.2.15.6. Analyst View
    • 5.2.15.7. Market Share

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
  • 6.1.3. Data Triangulation
• 6.2. Market Estimation and Forecast